RSS Subscribe to our Nanotechnology Business News feed

Access Pharmaceuticals Signs Agreement With Major Global Pharmaceutical Company for RNAi Therapeutic Delivery Technologies

Access Pharmaceuticals, Inc., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major pharmaceutical company to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.

Apr 13th, 2011

Read more

Nano Terra Acquires Surface Logix, Biomedical Development Firm

Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.

Apr 12th, 2011

Read more

EV Group Recognized as Leader in Nanoimprint Lithography With Frost Sullivan 2010 Technology Innovation Award

EV Group, a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today announced that it has received the 2010 European Nanoimprint Technology Product Innovation Award from independent market research firm, Frost + Sullivan. The prestigious award recognizes EVG's accomplishments in addressing industrial needs with nanoimprinting solutions.

Apr 11th, 2011

Read more